Mar 05, 2014 at 09:58 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Elder Pharmaceuticals, Lupin, Sun Pharmaceutical Industries, Cipla, Biocon and Aurobindo Pharma will get astrological support.
Feb 21, 2014 at 11:08 | Source: CNBC-TV18
Elder Pharma recently sold one of its key brands, Shelcal, to Torrent Pharma. Post the sale, Elder is focusing on remaining brands, including Eldervit and Somazina.
Feb 20, 2014 at 08:27 | Source: CNBC-TV18
DCM Shriram Consolidated | NTPC | Elder Pharma | Havells India | Greaves Cotton | Magma Fincorp | MCX | Jindal Steel | NMDC | Geodesic | Shiv Vani Oil | ESAB India | BHEL and Ranbaxy Labs are stocks, which are in the news today.
Feb 15, 2014 at 11:18 | Source: Moneycontrol.com
Elder Pharmaceuticals has reported a sales turnover of Rs 387.07 crore and a net loss of Rs 23.34 crore for the quarter ended Dec '13
Feb 10, 2014 at 10:54 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Sun Pharmaceutical Industries, Glenmark Pharma, Cipla, Dr Reddys Laboratories, Wockhardt and Elder Pharmaceuticals will get astrological support.
Feb 05, 2014 at 17:03 | Source: CNBC-TV18
In the long-term, Elder Pharma plans to bring products from the R&D pipeline, actively being worked on in the UK, and launch them in the Indian market, says Alok Saxena, Joint MD, Elder Pharma.
Jan 22, 2014 at 11:30 | Source: Moneycontrol.com
The company's overseas revenue grew by 41 percent to Rs 637 crore. "In the international operations, US Businesses reported growth of 61 percent, Europe (including Heumann) grew by 59 percent, Brazil operations' growth was 26 percent and rest of the world, including Russia, CIS, Mexico and Canada grew by 9 percent," the company statement said.
Dec 26, 2013 at 22:00 | Source: PTI
Elder Pharma's anti-infectives division has been contributing more than 10 percent to the total revenue and has been registering annual growth of more than 12 percent.
Dec 24, 2013 at 14:08 | Source: CNBC-TV18
According to Habil F Khorakiwala, India is becoming a research and manufacturing hub for global pharmaceutical generic companies and the Indian companies that have well established base in the generic space like Stride transaction are getting high valuation.
Dec 23, 2013 at 08:25 | Source: Moneycontrol.com
The pharmaceutical space has been buzzing and the Torrent Pharmaceuticals-Elder Pharmaceuticals deal remains in focus. CNBC-TV18s Ekta Batra gives more details on the acquisition.